A veteran of pharma and biotech reflects on a startup, drug prices, and politics- STAT

A veteran of pharma and biotech reflects on a startup, drug prices, and politics- STAT

STAT Plus: A pharma veteran best known for biotech reflects on leading a startup, pricing a drug, and investing in politics

By ADAM FEUERSTEIN AND DAMIAN GARDE AND REBECCA ROBBINS

ADOBE

Tony Coles may be best known for his success at Onyx. Now he's leading the neuroscience startup Yumanity Therapeutics.

READ MORE